Itih-4, a serine protease inhibitor regulated in interleukin-6-dependent liver formation: Role in liver development and regeneration

被引:46
作者
Bhanumathy, CD
Tang, Y
Monga, SPS
Katuri, V
Cox, JA
Mishra, B
Mishra, L
机构
[1] Temple Univ, Fels Inst Canc Res & Mol Biol, Lab Gastrointestinal Dev Mol Biol, Philadelphia, PA 19140 USA
[2] DVAMC, Washington, DC USA
[3] Univ Geneva, Dept Biochem, CH-1211 Geneva, Switzerland
[4] NHGRI, Clin Gene Therapy Branch, NIH, Bethesda, MD 20892 USA
关键词
ITIH-4; hyaluronic acid binding; ontogeny; liver regeneration; IL-6;
D O I
10.1002/dvdy.1235
中图分类号
R602 [外科病理学、解剖学]; R32 [人体形态学];
学科分类号
100101 ;
摘要
Inter-alpha -trypsin inhibitor-4 (Itih-4) is a liver-restricted member of the serine protease inhibitor family with diverse functions as an anti-apoptotic and matrix stabilizing molecule that are important throughout development. We investigate the functional role of Itih-4 in liver formation, regeneration (LR) and examine its role in calcium and hyaluronic acid binding. Itih-4 expression is prominent in early liver development at E9 and later at E16 being restricted to hepatoblasts, immature hepatocytes, and differentiated hepatocytes. We note a marked and differential increase in Itih-4 labeling in proliferating hepatocytes, compared with bile duct cells in liver explant cultures treated with interleukin-6 (IL-6). After partial hepatectomy, maximal Itih-4 expression occurs in a bimodal manner at 30 min and at 12 hr, with a predominant centrizonal distribution. There is no detectable binding of glutathione transferase-fusion Itih-4 protein to calcium and hyaluronic acid, indicating a possible requirement for posttranslational modifications for these functions. These results suggest that in LR, Itih-4 expression corresponds to that of immediate early genes and may contribute to the entry of normally quiescent hepatocytes into the early stages of the cell cycle. The markedly high expression of Itih-4 in early liver development and in explants treated with IL-6 suggests a prominent role for Itih-4 at key points in liver formation. (C) 2002 Wiley-Liss, Inc.
引用
收藏
页码:59 / 69
页数:11
相关论文
共 60 条
[21]   A new intracellular serine protease inhibitor expressed in the rat pituitary gland complexes with granzyme B [J].
Hill, RM ;
Morresey, KS ;
Coates, LC ;
Mezey, E ;
Fell, B ;
Bratt, T ;
Trapani, JA ;
Birch, NP .
FEBS LETTERS, 1998, 440 (03) :361-364
[22]   DIFFERENTIATION OF THE MOUSE HEPATIC PRIMORDIUM .1. AN ANALYSIS OF TISSUE INTERACTIONS IN HEPATOCYTE DIFFERENTIATION [J].
HOUSSAINT, E .
CELL DIFFERENTIATION, 1980, 9 (05) :269-279
[23]  
HUANG L, 1993, J BIOL CHEM, V268, P26725
[24]   BINDING OF HAPTOGLOBIN, INTER-ALPHA-TRYPSIN INHIBITOR, AND ALPHA-1-PROTEINASE INHIBITOR TO SYNOVIAL-FLUID HYALURONATE AND THE INFLUENCE OF THESE PROTEINS ON ITS DEGRADATION BY OXYGEN DERIVED FREE-RADICALS [J].
HUTADILOK, N ;
GHOSH, P ;
BROOKS, PM .
ANNALS OF THE RHEUMATIC DISEASES, 1988, 47 (05) :377-385
[25]  
Ikura M., 1996, TIBS, V21, P4
[26]   THE MESSENGER-RNA FOR A PROTEINASE-INHIBITOR RELATED TO THE HI-30 DOMAIN OF INTER-ALPHA-TRYPSIN INHIBITOR ALSO ENCODES ALPHA-1-MICROGLOBULIN (PROTEIN HC) [J].
KAUMEYER, JF ;
POLAZZI, JO ;
KOTICK, MP .
NUCLEIC ACIDS RESEARCH, 1986, 14 (20) :7839-7850
[27]   INHIBITORY EFFECT OF A CONJUGATE BETWEEN HUMAN UROKINASE AND URINARY TRYPSIN-INHIBITOR ON TUMOR-CELL INVASION IN-VITRO [J].
KOBAYASHI, H ;
GOTOH, J ;
HIRASHIMA, Y ;
FUJIE, M ;
SUGINO, D ;
TERAO, T .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (14) :8361-8366
[28]   Inter-alpha-trypsin inhibitor bound to tumor cells is cleaved into the heavy chains and the light chain on the cell surface [J].
Kobayashi, H ;
Gotoh, J ;
Hirashima, Y ;
Terao, T .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (19) :11362-11367
[29]   INHIBITION OF METASTASIS OF LEWIS-LUNG-CARCINOMA BY URINARY TRYPSIN-INHIBITOR IN EXPERIMENTAL AND SPONTANEOUS METASTASIS MODELS [J].
KOBAYASHI, H ;
SHINOHARA, H ;
FUJIE, M ;
GOTOH, J ;
ITOH, M ;
TAKEUCHI, K ;
TERAO, T .
INTERNATIONAL JOURNAL OF CANCER, 1995, 63 (03) :455-462
[30]   REGULATION OF SYNTHESIS OF SOME PROTEINASE-INHIBITORS IN HUMAN HEPATOMA-CELLS HEPG2 BY CYTOKINES, HEPATOCYTE GROWTH-FACTOR AND RETINOIC ACID [J].
KOJ, A ;
KORZUS, E ;
BAUMANN, H ;
NAKAMURA, T ;
TRAVIS, J .
BIOLOGICAL CHEMISTRY HOPPE-SEYLER, 1993, 374 (03) :193-201